Drug Class: Calcium Channel Blocker + Angiotensin Receptor Blocker (ARB) Maximum-Dose Combination | Form: Oral Tablet | Prescription Status: Prescription Only (Rx) — DRAP Registered
What is Amodip-V 10/160mg Tablet? Amodip-V 10/160mg contains maximum-dose Amlodipine 10mg combined with higher-dose Valsartan 160mg — the strongest available strength of this dual antihypertensive combination for patients whose blood pressure remains inadequately controlled on lower strength combinations including 5/80mg or 5/160mg formulations. At these higher individual doses both mechanisms deliver their maximum therapeutic blood pressure lowering effect simultaneously — Amlodipine at its ceiling dose produces complete peripheral calcium channel blockade while Valsartan at 160mg achieves substantially stronger and more sustained AT1 receptor blockade than lower doses. This high-strength combination is specifically indicated for difficult-to-control hypertension where maximum vasodilatory and maximum renin-angiotensin blockade are required together — providing comprehensive cardiovascular protection in high-risk patients through a single convenient daily tablet.
What is Amodip-V 10/160mg Used For?
- Resistant hypertension — blood pressure inadequately controlled on lower dose dual combinations (شدید ہائی بلڈ پریشر جو کم خوراک سے کنٹرول نہ ہو)
- Step-up from 5/80mg or 5/160mg combinations — uptitration to maximum strength when lower doses insufficient
- Hypertension with high cardiovascular risk — maximum dual-pathway protection in very high-risk patients (دل کی بیماری کے زیادہ خطرے میں بلڈ پریشر کنٹرول)
- Hypertension with diabetic nephropathy — maximum Valsartan dose provides strongest kidney protection (ذیابیطس میں گردوں کی زیادہ سے زیادہ حفاظت)
- Hypertension with left ventricular hypertrophy — maximising cardiac reverse remodelling benefit
- Simplifying complex regimens — replacing separate maximum-dose Amlodipine and Valsartan tablets
How Does it Work? Amlodipine 10mg at its maximum approved dose blocks L-type voltage-gated calcium channels in vascular smooth muscle with maximum completeness — producing the strongest peripheral arterial dilation and vascular resistance reduction achievable from Amlodipine monotherapy. Valsartan 160mg selectively blocks AT1 angiotensin II receptors with significantly greater receptor occupancy and more sustained blockade than lower doses — preventing angiotensin II-mediated vasoconstriction, aldosterone secretion, sodium retention, and pathological cardiovascular remodelling more completely than the 80mg dose. By combining ceiling-dose calcium channel blockade with high-dose AT1 receptor antagonism these two independent mechanisms produce additive blood pressure reduction through complementary pathways — achieving blood pressure control unattainable by either component alone even at maximum individual doses.
Dosage and Administration
⚠️ Never stop suddenly — dangerous rebound hypertension risk. Ankle swelling is significantly more common at maximum 10mg Amlodipine dose — report severe or rapidly worsening ankle swelling to doctor. Monitor kidney function and blood potassium regularly. Takes 2 to 4 weeks for full blood pressure effect at this higher strength. Can be taken with or without food at the same time each day.
| Indication | Usual Adult Dose | Frequency | Notes |
|---|---|---|---|
| Resistant hypertension | 1 tablet (10mg/160mg) | Once daily | Same time each day |
| Step-up from lower dose combination | 1 tablet (10mg/160mg) | Once daily | After tolerability confirmed at lower strength |
| High cardiovascular risk hypertension | 1 tablet (10mg/160mg) | Once daily | Under cardiologist supervision |
| Diabetic nephropathy | 1 tablet (10mg/160mg) | Once daily | Regular kidney function monitoring |
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amlodipine | 10mg |
| Valsartan | 160mg |
Who Should NOT Take Amodip-V 10/160mg?
- Allergy to Amlodipine, Valsartan, any dihydropyridine calcium channel blocker, any ARB, or any component
- Pregnancy — Valsartan strictly contraindicated in all trimesters; causes serious foetal kidney damage and death
- Breastfeeding
- Severe liver impairment — both components extensively hepatically metabolised; 10/160mg contraindicated
- Severe kidney impairment or bilateral renal artery stenosis
- Severe hypotension — systolic blood pressure below 90mmHg; maximum dose combination carries significant hypotension risk
- Cardiogenic shock
- Significant aortic stenosis — maximum dose Amlodipine contraindicated in severe aortic stenosis
- Hereditary angioedema or prior angioedema with any ARB or ACE inhibitor
- Concurrent Aliskiren use in patients with diabetes or kidney impairment
- Significant volume or sodium depletion — correct before starting maximum dose combination
- Children under 18 years
Side Effects
Common: Significant ankle swelling — peripheral oedema markedly more pronounced at maximum 10mg Amlodipine dose than lower strengths (ٹخنوں کی سوجن — 10mg پر زیادہ عام ہے), facial flushing and warmth, mild to moderate dizziness especially on standing (اٹھتے وقت چکر — زیادہ خوراک پر زیادہ امکان), mild headache, mild fatigue, mild palpitations — ankle swelling is the most frequent reason for dose reduction from 10mg back to 5mg Amlodipine.
Serious — Stop and seek emergency help immediately: Angioedema — sudden swelling of face, lips, tongue or throat with breathing difficulty (چہرے اور گلے کی سوجن — فوری ہسپتال جائیں), severely low blood pressure with fainting — particularly significant risk at this maximum dose combination (بے ہوشی — فوری مدد لیں), dangerous hyperkalaemia — severe muscle weakness and irregular heartbeat from Valsartan 160mg potassium retention (پٹھوں کی کمزوری اور دل کی دھڑکن میں خلل — فوری ڈاکٹر کو بتائیں), significant worsening of kidney function — reduced urination with ankle swelling and weight gain (فوری ڈاکٹر کو بتائیں), severe allergic reaction with widespread rash and breathing difficulty (فوری مدد لیں), significant worsening of angina shortly after starting maximum dose — rare vasodilatory reflex (فوری ہسپتال جائیں).
Drug Interactions
| Medicine | Interaction |
|---|---|
| ACE inhibitors (Enalapril, Lisinopril) | Significantly increased hyperkalaemia and acute kidney failure risk from Valsartan 160mg — avoid dual RAAS blockade |
| Aliskiren | Contraindicated in diabetes and kidney disease — increased hyperkalaemia and kidney damage risk |
| Potassium supplements / Potassium-sparing diuretics | Significantly increased hyperkalaemia risk from higher Valsartan 160mg dose — monitor closely |
| NSAIDs (Ibuprofen, Diclofenac) | Reduce antihypertensive effectiveness of both components and worsen kidney function — avoid regular combined use |
| Simvastatin at high doses | Maximum 10mg Amlodipine significantly increases Simvastatin exposure — limit Simvastatin strictly to 20mg daily; myopathy and rhabdomyolysis risk |
| Ketoconazole / Itraconazole | Increase Amlodipine blood levels — excessive hypotension risk at maximum 10mg dose |
| Cyclosporine / Tacrolimus | Both Amlodipine and Valsartan increase their blood levels at higher doses — nephrotoxicity risk; monitor closely |
| Lithium | Valsartan increases Lithium blood levels — toxicity risk at 160mg dose; monitor closely |
| Rifampicin | Reduces both Amlodipine and Valsartan blood levels — significantly reduced antihypertensive effectiveness |
| Sildenafil (Viagra) | Additive vasodilation — significant hypotension risk amplified at maximum Amlodipine 10mg dose; minimum 4 hours apart |
| Grapefruit juice | Increases Amlodipine blood levels significantly at 10mg — avoid completely |
| Alcohol (شراب) | Increases vasodilation and hypotension risk from both components — avoid excessive consumption |
Storage: Store below 25°C in a cool, dry place. Protect from moisture and direct sunlight. Keep in original packaging. Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں). Do not use after expiry date.
FAQs
Q: Why does Amodip-V 10/160mg cause more ankle swelling than the 5/80mg or 5/160mg strengths? Ankle swelling is a dose-dependent effect of Amlodipine's peripheral vasodilation — at the maximum 10mg dose this effect is significantly more pronounced than at 5mg, causing more frequent and sometimes troublesome peripheral oedema. While generally harmless, severe ankle swelling may require stepping down Amlodipine to 5mg — adding a diuretic or an ACE inhibitor/ARB component which counteracts Amlodipine-induced fluid shift into leg tissues rather than reducing the antihypertensive benefit.
Q: Is Amodip-V 10/160mg the strongest combination of Amlodipine and Valsartan available? Yes — 10mg is the maximum approved Amlodipine daily dose and 160mg Valsartan is the higher standard therapeutic dose. Exceeding 10mg Amlodipine provides no additional blood pressure benefit while significantly amplifying side effects. If blood pressure remains uncontrolled on this maximum dual combination, adding a third antihypertensive from a different class — such as Hydrochlorothiazide — is the clinically recommended next step rather than exceeding either individual maximum dose.
Q: Can Amodip-V 10/160mg be safely used in patients with both hypertension and diabetes? Yes — Valsartan 160mg provides meaningful kidney protection in diabetic nephropathy beyond blood pressure lowering, and Amlodipine does not impair glucose metabolism. However regular kidney function monitoring and blood potassium measurements are essential at this higher Valsartan dose — your diabetologist and cardiologist should jointly manage antihypertensive therapy in diabetic patients with cardiovascular and renal risk factors.
Medical Disclaimer: This information is for general awareness only and does not replace medical advice. Always consult a qualified doctor or pharmacist before taking any prescription medicine.